IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CLRB

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents33.998.3513.2012.5511.0413.9123.2934.2625.8740.039.5618.995.1512.6819.8717.7924.8130.6335.7040.34
Total Current Assets34.889.2714.0413.6212.6214.8924.2535.9027.9141.3710.4520.115.6113.8520.5318.7625.2931.3936.5741.39
Property, Plant & Equipment0.300.340.550.600.650.700.760.910.981.021.090.890.340.380.420.340.360.330.340.25
Total Non-current Assets*1.761.850.941.011.081.151.221.391.481.541.621.440.900.991.060.560.610.600.630.56
Total Assets36.6411.1214.9814.6313.7016.0425.4737.2929.3842.9112.0821.556.5114.8421.5919.3225.8931.9937.2041.95
Accounts Payable5.224.724.424.014.683.877.598.306.467.399.187.816.396.905.486.375.464.513.853.03
Total Current Liabilities5.244.874.754.915.876.029.3920.3115.1728.5525.3616.476.456.965.536.525.614.653.993.17
Total Non-current Liabilities*1.531.530.310.340.360.390.410.430.450.470.490.510.530.550.550.050.090.130.170.20
Total Liabilities6.776.405.065.256.236.419.8020.7515.6229.0325.8516.986.987.506.086.575.704.784.163.37
Retained Earnings(281.72)(274.79)(269.13)(263.84)(259.39)(253.95)(247.34)(244.99)(230.32)(229.40)(202.76)(210.03)(196.30)(179.50)(179.50)(172.28)(164.47)(150.90)--(144.98)
Total Stockholder Equity29.873.348.548.006.098.2514.2915.1612.3812.50(15.16)(13.35)(0.47)7.3315.5112.7520.1927.2133.0538.59
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Research & Development4.563.013.162.522.393.436.215.497.357.096.997.316.316.655.455.384.503.894.393.94
Selling, General & Admin2.642.792.532.333.652.976.547.836.364.915.562.101.992.051.972.442.942.251.541.88
Operating Income(7.20)(5.79)(5.69)(4.85)(6.04)(6.40)(12.74)(13.33)(13.70)(12.00)(12.55)(9.41)(8.29)(8.71)(7.42)(7.82)(7.44)(6.14)(5.92)(5.82)
Net Income(6.93)(5.65)(5.30)(4.44)(5.45)(6.60)(2.36)(14.66)(0.92)(26.64)(12.24)(13.73)(8.22)--(7.22)(7.81)(7.44)--(5.92)(5.82)
Basic EPS(0.57)(1.33)(3.41)(1.41)(3.39)(0.14)(0.08)(0.37)(0.03)(0.91)(0.41)(1.21)(0.73)(0.76)(1.45)(1.28)(1.22)(0.10)(0.09)(0.10)
Diluted EPS(0.57)(1.33)(3.41)(1.41)(3.39)(0.14)(0.08)(0.40)(0.18)(0.91)(0.41)(1.21)(0.73)(0.76)(1.45)(1.28)(1.22)(0.10)(0.42)(0.10)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(6.01)(4.85)(4.34)(4.28)(5.12)(9.38)(10.91)(9.17)(14.14)(13.36)(9.60)(8.07)(7.53)(7.18)(7.41)(7.01)(5.76)(5.04)(4.51)(6.43)
Capital Expenditures0.000.00--------0.060.000.020.020.270.60----0.120.010.070.030.130.00
Free Cash Flow*(6.01)(4.85)--------(10.97)(9.17)(14.16)(13.38)(9.86)(8.67)----(7.53)(7.02)(5.83)(5.07)(4.64)(6.43)
Investing Cash Flow0.00-0.00--------(0.06)0.00(0.02)(0.02)(0.27)(0.60)----(0.12)(0.01)(0.07)(0.03)(0.13)-0.00
Financing Cash Flow31.66--4.995.792.25--0.0017.560.0043.850.4422.500.000.00---------0.000.00
← Scroll for more columns →

* Derived from reported values